Song Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Song Wu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Hongyang Sang
Department of Thoracic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 201306, China
3 shared publicationsShaofei Cheng
Department of Thoracic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 201306, China
3 shared publicationsZhengyang Fan
Department of Thoracic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 201306, China
3 shared publicationsLinlin Xie
Department of foundation courses, AnHui Medical College, Hefei 230000, China
2 shared publicationsQianping Li
Department of Thoracic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 201306, China
2 shared publications- Andy Peng Xiang
Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-Sen University, Guangzhou 510080, China
1 shared publication
Latest Publications
- 19 May 2026
- Published by Elsevier in Pathology - Research and Practice
- Vol. 285, 156548
B4GALNT4 promotes lung cancer progression by suppressing ferroptosis through glycosylation of SLC7A11
- 19 May 2026
- Published by Elsevier in Pathology - Research and Practice
- Vol. 285, 156548
B4GALNT4 promotes lung cancer progression by suppressing ferroptosis through glycosylation of SLC7A11
- 7 January 2022
- Published by Elsevier in Pathology - Research and Practice
- Vol. 232, 153762
UBE4B promotes the development of lung adenocarcinoma by enhancing proliferation, migration and glycolysis via PP2A/AKT signaling
- 7 January 2022
- Published by Elsevier in Pathology - Research and Practice
- Vol. 232, 153762
UBE4B promotes the development of lung adenocarcinoma by enhancing proliferation, migration and glycolysis via PP2A/AKT signaling
- 17 September 2021
- Published by Taylor & Francis in Personalized Medicine
- Vol. 19 (3) , 193-205
SKA3 , negatively regulated by miR-128-3p , promotes the progression of non-small-cell lung cancer
Aim: To investigate the effects of SKA3 on cell proliferation and metastasis in non-small-cell lung cancer (NSCLC) and its underlying mechanism. Methods: Immunohistochemistry was employed to analyz... Lay abstract It is reported that the protein SKA3 can promote the growth and spread of cancer cells in multiple tumors. However, the biological role and action of SKA3 in the progression of non-sma...
- 17 September 2021
- Published by Taylor & Francis in Personalized Medicine
- Vol. 19 (3) , 193-205
SKA3 , negatively regulated by miR-128-3p , promotes the progression of non-small-cell lung cancer
Aim: To investigate the effects of SKA3 on cell proliferation and metastasis in non-small-cell lung cancer (NSCLC) and its underlying mechanism. Methods: Immunohistochemistry was employed to analyz... Lay abstract It is reported that the protein SKA3 can promote the growth and spread of cancer cells in multiple tumors. However, the biological role and action of SKA3 in the progression of non-sma...
- Open Access
- 6 January 2021
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (1) , 1-17
LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells
Long non-coding RNA (lncRNA) DANCR has been reported to participate in key processes such as stem cell differentiation and tumorigenesis. In a high throughput screening for lncRNAs involved in Doxorubicin-induced apoptosis, we found DANCR was suppressed by Doxorubicin and it acted as an important repressor of apoptosis in colorectal cancer. Further studies demonstrated that DANCR promoted the oncogenic lncRNA MALAT1 expression via enhancing the RNA stability of MALAT1 to suppress apoptosis. MALAT1 could efficiently mediate the suppressive function of DANCR on apoptosis. Mechanistic studies found the RNA-binding protein QK served as an interacting partner of both DANCR and MALAT1, and the protein level of QK was subjected to the regulation by DANCR. Furthermore, QK was able to modulate the RNA stability of MALAT1, and the interaction between QK and MALAT1 was controlled by DANCR. In addition, QK could mediate the function of DANCR in regulating the expression of MALAT1 and suppressing apoptosis. These results revealed DANCR played a critical role in Doxorubicin-induced apoptosis in colorectal cancer cells, which was achieved by the interaction between DANCR and QK to enhance the expression of MALAT1.
- 6 January 2021
- Published by Springer Nature in Cell Death & Disease
- Vol. 12 (1) , 1-17
Open AccessLncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells
Long non-coding RNA (lncRNA) DANCR has been reported to participate in key processes such as stem cell differentiation and tumorigenesis. In a high throughput screening for lncRNAs involved in Doxorubicin-induced apoptosis, we found DANCR was suppressed by Doxorubicin and it acted as an important repressor of apoptosis in colorectal cancer. Further studies demonstrated that DANCR promoted the oncogenic lncRNA MALAT1 expression via enhancing the RNA stability of MALAT1 to suppress apoptosis. MALAT1 could efficiently mediate the suppressive function of DANCR on apoptosis. Mechanistic studies found the RNA-binding protein QK served as an interacting partner of both DANCR and MALAT1, and the protein level of QK was subjected to the regulation by DANCR. Furthermore, QK was able to modulate the RNA stability of MALAT1, and the interaction between QK and MALAT1 was controlled by DANCR. In addition, QK could mediate the function of DANCR in regulating the expression of MALAT1 and suppressing apoptosis. These results revealed DANCR played a critical role in Doxorubicin-induced apoptosis in colorectal cancer cells, which was achieved by the interaction between DANCR and QK to enhance the expression of MALAT1.